2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
6
Polycystic Ovary Syndrome
5
Obesity
5
Neoplasms
3
Motor Activity
3
Ovarian Diseases
2
Ovarian Cysts
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Feeding Behavior
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neuroendocrine Tumors
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Growth Hormone-Secreting Pituitary Adenoma
1
Fibrosis
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Interventions
Cyclophosphamide
87
fludarabine phosphate
86
Peripheral Blood Stem Cell Transplantation
71
Mycophenolic Acid
58
Tacrolimus
57
Busulfan
57
Whole-Body Irradiation
55
Antilymphocyte Serum
47
Cyclosporine
46
fludarabine
39
Methotrexate
38
Filgrastim
38
Melphalan
32
ruxolitinib
30
Cytarabine
30
Radiotherapy
27
Azacitidine
23
Etoposide
21
Methylprednisolone
20
Cord Blood Stem Cell Transplantation
18
Specimen Handling
15
Sirolimus
15
Granulocyte Colony-Stimulating Factor
15
Decitabine
15
Biopsy
15
Flow Cytometry
14
Cyclosporins
14
Alemtuzumab
14
thymoglobulin
13
venetoclax
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Diet, Mediterranean
×
Clear all
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled